DUBLIN, IRELAND--(Marketwire - September 26, 2007) - Trinity Biotech plc (NASDAQ: TRIB) (DUBLIN: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced that Trinity Biotech is celebrating its 15th listing anniversary on NASDAQ this year. To celebrate and mark the occasion, Brendan Farrell, President, will host the closing ceremony in NASDAQ’s New York Times Square offices at 4:00 p.m. Eastern Time, on Tuesday the 2nd of October.
